Skip to main content

Table 2 Results of multivariate analysis of the factors predicting febrile neutropenia

From: Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil

Variables

Odds ratio

95% CI

p value

Non-use of pegfilgrastim

16.393

2.049–125.0

0.008

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us